This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.
Dr. Neera Sammeta, Emerging Business Manager at Roche CustomBiotech, discusses the future of mRNA technology and its potential beyond infectious disease vaccines at the TIDES USA conference in San Diego, California.
